Test Price
800 AED✅ Home Collection Available
Cytochrome P450 2C19 Genotyping (CYP2C19) Clopidogrel Resistance (*2,*3,*4,*10) in UAE | 800 AED | 2026 DHA Guidelines
تحليل السيتوكروم بي450 2سي19 (CYP2C19) لمقاومة عقار كلوبيدوجريل في الإمارات | 800 درهم | معتمد من هيئة الصحة بدبي 2026
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing at our UAE facility.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy across Dubai, Abu Dhabi, Sharjah.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed genetic counselors.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي: يقدم هذا التحليل الجيني المتطور للكشف عن مقاومة عقار كلوبيدوجريل بدقة التشخيص 99.9% عبر مختبراتنا المعتمدة دولياً وفقاً لمعايير هيئة الصحة بدبي. خدمة الإجراء المنزلي المميزة وشرح النتائج بعد الإختبار توفر لك أعلى مستويات الرعاية والموثوقية.
Clinical Overview
This pharmacogenetic test identifies inherited variants in the CYP2C19 gene—specifically loss-of-function alleles *2, *3, *4, and *10—that predict poor metabolism of the antiplatelet drug clopidogrel, enabling personalized anti-thrombotic therapy. Preferred by Gynecologists managing post-menopausal cardiovascular risk, Anti-Aging Specialists optimizing longevity therapies, and Family Medicine Physicians ensuring safe chronic pharmacotherapy. يعتمد الأطباء على هذا التحليل لتجنب فشل العلاج الدوائي لدى مرضى القلب والأوعية الدموية.
| Feature | Our Test (UAE Golden Standard) | Standard Genotyping |
|---|---|---|
| Precision | Sanger Sequencing (Gold Standard), 100% allele coverage for *2, *3, *4, *10 | PCR-RFLP or targeted arrays, may miss rare variants |
| Turnaround | 7 Working Days (Expedited Available) | 10–14 Days |
| Clinical Reporting | DHA-compliant, actionable phenotype: Extensive, Intermediate, Poor Metabolisers | Basic genotype only |
Physician Insight & Safety Protocol
“As a clinician, I emphasize that CYP2C19 genotyping is not a stand-alone decision tool. Results must be interpreted alongside bleeding risk assessment, comorbidities, and concurrent medications. Do not discontinue prescribed clopidogrel without consulting your cardiologist or prescribing doctor.” — Dr. PRABHAKAR REDDY, DHA-Licensed Specialist (License: 61713011), ISO-Certified Laboratory Director.
⚠ Medication Safety Warning
Do not discontinue prescribed medication without consulting your doctor. Abruptly stopping antiplatelet therapy can trigger stent thrombosis or life-threatening cardiovascular events. This test is intended to guide therapeutic adjustments only under direct medical supervision.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Patients with active bleeding, known hypersensitivity to anticoagulants, or recent major surgery within 30 days are not suitable for home sample collection without prior stabilization.
- Exclusion: Pregnant or breastfeeding women require specific DHA-approved consent forms.
- Red Flag: If you experience sudden chest pain, shortness of breath, or uncontrolled bleeding after test, call 998 immediately.
Patient FAQ & Clinical Guidance
Q: What does the CYP2C19 genotype mean for my clopidogrel therapy?
Snippet: CYP2C19 genotyping identifies whether you are a normal, intermediate, or poor metaboliser of clopidogrel, directly impacting the drug’s effectiveness in preventing heart attacks and strokes. Poor metabolisers may have up to a 3-fold higher risk of stent thrombosis and require alternative antiplatelet strategies such as prasugrel or ticagrelor, always under specialist guidance.
س: ماذا تعني نتائج تحليل CYP2C19 بالنسبة لعلاجي بعلاج الكلوبيدوجريل؟
الإجابة المختصرة: يكشف تحليل CYP2C19 عن قدرتك الوراثية على استقلاب عقار كلوبيدوجريل، حيث تظهر النتائج أن ما يصل إلى 30% من السكان لديهم استقلاب ضعيف مما يزيد خطر فشل العلاج بشكل كبير.
Q: Is a doctor’s prescription required for this test in the UAE?
Snippet: Yes, a valid DHA-registered doctor’s prescription is mandatory for CYP2C19 genotyping to ensure clinical appropriateness and compliance with Federal Decree-Law No. 41 of 2024, except for surgery planning, pregnancy cases, or travel clearance where alternative pre- requirements apply.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians